Chaucer Life Sciences are looking forward to discussing industry challenges and opportunities at DIA this year in Boston. Our focus will be on the opportunity to help our clients to further improve people’s lives.
DIA (Drug Information Association) is a global association that mobilizes life science professionals from across all areas of expertise to engage with patients, peers and thought leaders in a neutral environment on the issues of today and the possibilities for tomorrow.
Their DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe and we are proud to be an exhibitor.
Some of the topics we will discuss include the implementation of ICH e6 R2, Post Merger Integration, Digital Transformation and our involvement in the iMatch program for advanced therapeutics.
Come and visit us as we consider these and other themes at our stand 634 on Monday 25th June to Wednesday 27th June 2018.
Below are some of the literature available when you visit us at DIA 2018. If you’re not able to attend, please feel free to download the following PDFs:
ICH E6 (R2)
We have taken the core elements of R2 and delivered something for our clients that takes their implementation of R2 from compliance to opportunity. We support all ares of change for R2 but core elements we highlight are …. to continue reading, click here to view this PDF ›
Post Merger Integration
Organizations must overcome many challenges after an acquisition in order to unifry an streamline technology, data, content, and business processes across the entire enterprise. It is crucial for organizations to quickly integrate …. to continue reading, click here to view this PDF ›
Digital Transformation in the Life Science Industry is changing the way we design and deliver the future of clinical trials. This exciting journey introduces technology and analytics which could revolutionize drug development …. to continue reading, click here to view this PDF ›
IMATCH is a Manchester based consortium which is one of three centres in the United Kingdom to be awarded funding by Innovate UK to coordinate scale-up of advanced therapies for a range of debilitating conditions. Our vision is …. to continue reading, click here to view this PDF ›
Digital Privacy & Clinical Research
Chaucer Life Sciences have been working with organizations involved in the control and processing of clinical data to support them with their GDPR compliance. We have a dedicated GDPR Life Science team made up of Data Privacy …. to continue reading, click here to view this PDF ›
Our consultants are looking forward to discussing your current industry opportunities and we have experts in hand to talk about Digital Transformation in Life Sciences, moving from compliance to opportunity with ICH E6 (R2) and Post-Merger Integration & Digital Asset Management.
Our GDPR expert is available to discuss the impact on Clinical Trials and we’ll be sharing information about our involvement in iMATCH (Innovate Manchester Advanced Therapies Centre Hub).
The Chaucer Life Sciences team will also have demonstrations of how we have utilised the Sharp Cloud toolset to show value and linkage across your data sources.